Technical Analysis for MNTA - Momenta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 29.68 -4.23% -1.31
MNTA closed down 1.56 percent on Monday, June 1, 2020, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MNTA trend table...

Date Alert Name Type % Chg
NR7 Range Contraction -4.23%
Down 3 Days in a Row Weakness -4.23%
Down 4 Days in a Row Weakness -4.23%
Hammer Candlestick Bullish -5.72%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.72%
Down 3 Days in a Row Weakness -5.72%
Fell Below 20 DMA Bearish -6.40%
MACD Bearish Signal Line Cross Bearish -6.40%
Inside Day Range Contraction -6.40%
20 DMA Support Bullish -8.93%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Momenta Pharmaceuticals, Inc., a biotechnology company, engages in the structural characterization, process engineering, and biologic systems analysis of complex molecules. Its complex molecules include polysaccharides, polypeptides, and proteins and antibodies. The company's complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a glatiramer acetate injection indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. Its biosimilars programs include M923, a biosimilar for autoimmune and inflammatory diseases; M834 for autoimmune and inflammatory diseases; and M511, a monoclonal antibody for oncology. The company's novel products comprise M402, a novel heparan sulfate mimetic that binds to various growth factors, adhesion molecules, and chemokines to inhibit tumor angiogenesis, progression, and metastasis; and the sialylation technology, which is a discovery program that is intended to modify immunoglobulin G antibodies in intravenous immunoglobulin, a drug to treat autoimmune and inflammatory diseases. It has collaboration agreements with Sandoz AG; Baxter International, Inc.; Baxter Healthcare Corporation; and Baxter Healthcare SA. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology Immunology Antibodies Immune System Antibody Tumor Monoclonal Antibody Autoimmunity Autoimmune And Inflammatory Diseases Glycoproteins Metastasis Biosimilar Deep Vein Thrombosis Relapsing Remitting Multiple Sclerosis Acute Coronary Syndromes Immunoglobulin Therapy

Is MNTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 35.13
52 Week Low 9.51
Average Volume 1,027,768
200-Day Moving Average 22.23
50-Day Moving Average 29.91
20-Day Moving Average 31.93
10-Day Moving Average 31.86
Average True Range 2.15
ADX 14.55
+DI 24.22
-DI 23.19
Chandelier Exit (Long, 3 ATRs ) 28.68
Chandelier Exit (Short, 3 ATRs ) 34.15
Upper Bollinger Band 34.48
Lower Bollinger Band 29.37
Percent B (%b) 0.32
BandWidth 16.02
MACD Line 0.38
MACD Signal Line 0.55
MACD Histogram -0.1736
Fundamentals Value
Market Cap 2.29 Billion
Num Shares 73.8 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -48.42
Price-to-Sales 9.20
Price-to-Book 2.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.64
Resistance 3 (R3) 32.74 32.30 32.37
Resistance 2 (R2) 32.30 31.88 32.25 32.27
Resistance 1 (R1) 31.64 31.62 31.42 31.54 32.18
Pivot Point 31.20 31.20 31.09 31.15 31.20
Support 1 (S1) 30.54 30.78 30.32 30.44 29.80
Support 2 (S2) 30.10 30.52 30.05 29.71
Support 3 (S3) 29.44 30.10 29.62
Support 4 (S4) 29.34